Omeros Corporation
OMER
$3.73
Share price
0.27%
Change (1 day)
-24.95%
Change (1 year)
Categories
Omeros Corporation (OMER) - Total debt
Total debt on the balance sheet as of September 2023 : $0.34 B
According to Omeros Corporation's latest financial reports the company's total debt is $0.34 B. A company’s total debt is the sum of all current and non-current debts.
Omeros Corporation - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.34 B | -1.67% |
| 2021-12-31 | $0.34 B | 29.39% |
| 2020-12-31 | $0.26 B | 38.55% |
| 2019-12-31 | $0.19 B | 28.12% |
| 2018-12-31 | $0.15 B | 79% |
| 2017-12-31 | $84.6 M | 6.14% |
| 2016-12-31 | $79.71 M | 59.93% |
| 2015-12-31 | $49.84 M | 53.58% |
| 2014-12-31 | $32.45 M | 58.32% |
| 2013-12-31 | $20.49 M | 1.96% |
| 2012-12-31 | $20.1 M | 3.38% |
| 2011-12-31 | $19.44 M | 99.34% |
| 2010-12-31 | $9.75 M | -23.54% |
| 2009-12-31 | $12.75 M | -23.49% |
| 2008-12-31 | $16.67 M | 1550.89% |
| 2007-12-31 | $1.01 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 8,504.94% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 20,683.34% | 🇺🇸 USA |
 Genetic Technologies GENE | $0.26 M | -99.92% | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | $41.84 M | -87.72% | 🇺🇸 USA |